Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Efficacy of Lebrikizumab in Patients With Severe Atopic Dermatitis Who Would be Eligible for Treatment Based on the South Korean Reimbursement Criteria

Saved in:
Bibliographic Details
Published in:JEADV Clinical Practice
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1868553596863250433
collection WordPress RSS
FRELIP Feed Integration
container_title JEADV Clinical Practice
description
discipline_display Dermatology and Venereology
discipline_facet Dermatology and Venereology
format Online Article
RSS Article
genre Journal Article
id rss_article:76748
institution FRELIP
journal_source_facet JEADV Clinical Practice
last_indexed 2026-06-20T21:39:33.054Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Efficacy of Lebrikizumab in Patients With Severe Atopic Dermatitis Who Would be Eligible for Treatment Based on the South Korean Reimbursement Criteria
Dermatology and Venereology
General
Dermatology and Venereology
sub_discipline_display General
sub_discipline_facet General
subject_display Dermatology and Venereology
General
Dermatology and Venereology
subject_facet Dermatology and Venereology
General
Dermatology and Venereology
title Efficacy of Lebrikizumab in Patients With Severe Atopic Dermatitis Who Would be Eligible for Treatment Based on the South Korean Reimbursement Criteria
title_alt Eficacia de lebrikizumab en pacientes con dermatitis atópica grave que serían elegibles para tratamiento según los criterios de reembolso de Corea del Sur
Efficacité du lébrikizumab chez les patients atteints de dermatite atopique sévère qui seraient éligibles au traitement selon les critères de remboursement sud-coréens
Eficácia do Lebrikizumabe em Pacientes com Dermatite Atópica Grave que Seriam Elegíveis para Tratamento com Base nos Critérios de Reembolso Sul-Coreanos
title_auth Efficacy of Lebrikizumab in Patients With Severe Atopic Dermatitis Who Would be Eligible for Treatment Based on the South Korean Reimbursement Criteria
title_es_txt Eficacia de lebrikizumab en pacientes con dermatitis atópica grave que serían elegibles para tratamiento según los criterios de reembolso de Corea del Sur
title_fr_txt Efficacité du lébrikizumab chez les patients atteints de dermatite atopique sévère qui seraient éligibles au traitement selon les critères de remboursement sud-coréens
title_full Efficacy of Lebrikizumab in Patients With Severe Atopic Dermatitis Who Would be Eligible for Treatment Based on the South Korean Reimbursement Criteria
title_fullStr Efficacy of Lebrikizumab in Patients With Severe Atopic Dermatitis Who Would be Eligible for Treatment Based on the South Korean Reimbursement Criteria
title_full_unstemmed Efficacy of Lebrikizumab in Patients With Severe Atopic Dermatitis Who Would be Eligible for Treatment Based on the South Korean Reimbursement Criteria
title_pt_txt Eficácia do Lebrikizumabe em Pacientes com Dermatite Atópica Grave que Seriam Elegíveis para Tratamento com Base nos Critérios de Reembolso Sul-Coreanos
title_short Efficacy of Lebrikizumab in Patients With Severe Atopic Dermatitis Who Would be Eligible for Treatment Based on the South Korean Reimbursement Criteria
title_sort efficacy of lebrikizumab in patients with severe atopic dermatitis who would be eligible for treatment based on the south korean reimbursement criteria
topic Dermatology and Venereology
General
Dermatology and Venereology
url https://onlinelibrary.wiley.com/doi/10.1002/jvc2.70271?af=R